Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: a web-based, double-blind survey of EU clinicians

BACKGROUND: The prognosis for adult patients with Ph(-) B-precursor acute lymphoblastic leukaemia (ALL) who are refractory to treatment or experience relapse (R/R), is poor; over 90 % of these patients die from the disease, typically within a few months. While there are some national guidelines publ...

Descripción completa

Detalles Bibliográficos
Autores principales: Saltman, Deborah, Barlev, Arie, Seshagiri, Divyagiri, Katsoulis, Ioannis, Lin, Vincent, Barber, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619337/
https://www.ncbi.nlm.nih.gov/pubmed/26498125
http://dx.doi.org/10.1186/s12885-015-1745-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619337/
https://www.ncbi.nlm.nih.gov/pubmed/26498125
http://dx.doi.org/10.1186/s12885-015-1745-4

Ejemplares similares